NPs Basic Information

Name
Crinamidine
Molecular Formula C17H19NO5
IUPAC Name*
(1S,13R,15R,16S,18R)-9-methoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.01,13.02,10.04,8.016,18]icosa-2,4(8),9-trien-15-ol
SMILES
COC1=C2CN3CC[C@@]4([C@H]3C[C@H]([C@H]5[C@@H]4O5)O)C2=CC6=C1OCO6
InChI
InChI=1S/C17H19NO5/c1-20-13-8-6-18-3-2-17(9(8)4-11-15(13)22-7-21-11)12(18)5-10(19)14-16(17)23-14/h4,10,12,14,16,19H,2-3,5-7H2,1H3/t10-,12-,14+,16+,17+/m1/s1
InChIKey
HHEOZJCKMANJQV-CUQLUGJVSA-N
Synonyms
crinamidine; NSC709877; NSC-709877; C12168; CHEBI:31436; Q27114310; (1S,13R,15R,16S,18R)-9-methoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.01,13.02,10.04,8.016,18]icosa-2,4(8),9-trien-15-ol; 6793-66-4
CAS NA
PubChem CID 399204
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Alkaloids and derivatives
      • Class: Amaryllidaceae alkaloids
        • Subclass: Crinine- and Haemanthamin
          • Direct Parent: Crinine- and Haemanthamin

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 317.34 ALogp: 0.8
HBD: 1 HBA: 6
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 63.7 Aromatic Rings: 6
Heavy Atoms: 23 QED Weighted: 0.785

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.353 MDCK Permeability: 0.00002340
Pgp-inhibitor: 0.002 Pgp-substrate: 0.965
Human Intestinal Absorption (HIA): 0.003 20% Bioavailability (F20%): 0.007
30% Bioavailability (F30%): 0.523

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.992 Plasma Protein Binding (PPB): 22.47%
Volume Distribution (VD): 2.275 Fu: 63.31%

ADMET: Metabolism

CYP1A2-inhibitor: 0.173 CYP1A2-substrate: 0.879
CYP2C19-inhibitor: 0.086 CYP2C19-substrate: 0.848
CYP2C9-inhibitor: 0.017 CYP2C9-substrate: 0.617
CYP2D6-inhibitor: 0.758 CYP2D6-substrate: 0.697
CYP3A4-inhibitor: 0.677 CYP3A4-substrate: 0.702

ADMET: Excretion

Clearance (CL): 13.086 Half-life (T1/2): 0.608

ADMET: Toxicity

hERG Blockers: 0.227 Human Hepatotoxicity (H-HT): 0.748
Drug-inuced Liver Injury (DILI): 0.054 AMES Toxicity: 0.113
Rat Oral Acute Toxicity: 0.73 Maximum Recommended Daily Dose: 0.891
Skin Sensitization: 0.087 Carcinogencity: 0.778
Eye Corrosion: 0.003 Eye Irritation: 0.011
Respiratory Toxicity: 0.941
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001089 0.617 D0T6RC 0.300
ENC002961 0.307 D04TDQ 0.277
ENC000702 0.293 D03DIG 0.262
ENC003230 0.283 D0X5KF 0.250
ENC000361 0.246 D0D4HN 0.246
ENC002626 0.245 D0L1JW 0.246
ENC003767 0.224 D0R9VR 0.245
ENC004130 0.222 D03SKD 0.234
ENC000812 0.216 D04JHN 0.233
ENC002159 0.216 D0WE3O 0.233
*Note: the compound similarity was calculated by RDKIT.